Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Tóm tắt
Từ khóa
Tài liệu tham khảo
Moghimi, 2001, Long-circulating and target-specific nanoparticles, Pharm Rev, 53, 283
Curtis, 2001, Nanotechniques and approaches in biotechnology, Trends Biotech, 19, 97, 10.1016/S0167-7799(00)01536-5
Wilkinson, 2003, Nanotechnology applications in medicine, Med Device Technol, 14, 29
Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv Drug Del Rev, 55, 329, 10.1016/S0169-409X(02)00228-4
Siegel RW. In: Siegel RW, Hu E, Roco MC editors. Nanostructure science and technology. A worldwide study. WTEC, Loyola College in Maryland; 1999.
Uchegbu, 1996, Adverse drug events related to dosage forms and delivery systems, Drug Saf, 14, 39, 10.2165/00002018-199614010-00005
Gilchrist, 1957, Selective inductive heating of lymph nodes, Ann Surg, 146, 596, 10.1097/00000658-195710000-00007
Schwertmann, 1991
Cornelis, 1977
Kwei, 1990, Structure and valence from complementary anomalous X-ray and neutron powder diffraction, J Molecul Struct, 223, 383, 10.1016/0022-2860(90)80482-Y
Babincova, 2001, High-gradient magnetic capture of ferrofluids, Z Naturforsch (Sect C), 56, 909, 10.1515/znc-2001-9-1039
Wang, 2001, Superparamagnetic iron oxide contrast agents, Eur Radiol, 11, 2319, 10.1007/s003300100908
Bonnemain, 1998, Superparamagnetic agents in magnetic resonance imaging, J Drug Target, 6, 167, 10.3109/10611869808997890
Babes, 1999, Synthesis of iron oxide nanoparticles used as MRI contrast agents, J Coll Int Sci, 212, 474, 10.1006/jcis.1998.6053
Goya, 2003, Static and dynamic magnetic properties of spherical magnetite nanoparticles, J Appl Phys, 94, 3520, 10.1063/1.1599959
Arbab, 2003, Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging, Radiology, 229, 838, 10.1148/radiol.2293021215
Reimer, 1996, Development and experimental application of receptor-specific MR contrast media, Radiology, 36, 153, 10.1007/s001170050053
Pankhurst, 2003, Applications of magnetic nanoparticles in biomedicine, J Phys D, 36, R167, 10.1088/0022-3727/36/13/201
1997
Berry, 2003, Functionalisation of magnetic nanoparticles for applications in biomedicine, J Phys D, 36, R198, 10.1088/0022-3727/36/13/203
Tartaj, 2003, The preparation of magnetic nanoparticles for applications in biomedicine, J Phys D, 36, R182, 10.1088/0022-3727/36/13/202
Jordan, 2001, Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia, J Magn Magn Mater, 225, 118, 10.1016/S0304-8853(00)01239-7
Chatterjee, 2003, Size dependent magnetic properties of iron oxide nanoparticles, J Magn Magn Mater, 257, 113, 10.1016/S0304-8853(02)01066-1
Pratsinis, 1996, Particle formation in gases—a review, Powder Technol, 88, 267, 10.1016/S0032-5910(96)03130-0
Stolnik, 1995, Long circulating microparticulate drug carriers, Adv Drug Del Rev, 16, 195, 10.1016/0169-409X(95)00025-3
Kodas, 1999
Lee, 2001, Microelectromagnets for the control of magnetic nanoparticles, Appl Phys Lett, 79, 3308, 10.1063/1.1419049
Rishton, 1997, Magnetic tunnel junctions fabricated at tenth-micron dimensions by electron beam lithography, Microelectron Eng, 35, 249, 10.1016/S0167-9317(96)00107-4
Gupta, 2004, Surface modified superparamagnetic nanoparticles for drug delivery, IEEE Trans Nanobiosci, 3, 66, 10.1109/TNB.2003.820277
Charles, 1992, Magnetic fluids (ferrofluids), 267
Gupta, 2004, Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors, Biomaterials, 25, 3029, 10.1016/j.biomaterials.2003.09.095
Reimers, 1972, Preparing magnetic fluids by a peptizing method, US Bureau Mines Tech Rep, 59
Hadjipanayis GC, Siegel RW. Nanophase materials: synthesis, properties and applications. NATO ASI Series, Applied Sciences, vol. E260. Dordrecht: Kluwer; 1993.
Sjogren, 1994, Magnetic characterization of iron oxides for magnetic resonance imaging, Magn Reson Med, 31, 268, 10.1002/mrm.1910310305
Cornell, 1991
Cotton, 1988
Kim, 2001, Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles, J Magn Magn Mater, 225, 30, 10.1016/S0304-8853(00)01224-5
Boistelle, 1988, Crystallization mechanisms in solution, J Cryst Growth, 90, 14, 10.1016/0022-0248(88)90294-1
Banfield, 2000, Aggregation-based crystal growth and microstructure development in natural iron oxyhydroxide biomineralization products, Science, 289, 751, 10.1126/science.289.5480.751
Penn, 1999, Morphology development and crystal growth in nanocrystalline aggregates under hydrothermal conditions, Geochim Cosmochim Acta, 63, 1549, 10.1016/S0016-7037(99)00037-X
Chemseddine, 1999, Nanostructuring Titania, Eur J Inorg Chem, 2, 235, 10.1002/(SICI)1099-0682(19990202)1999:2<235::AID-EJIC235>3.0.CO;2-N
Verges, 1990, Formation of rod-like zinc oxide microcrystals in homogenous solutions, J Chem Soc Faraday Trans, 86, 959, 10.1039/FT9908600959
Taylor, 2001, Structural and morphological anomalies in magnetosomes, J Microsc, 201, 84, 10.1046/j.1365-2818.2001.00760.x
Zhou, 2001, Granular growth of Fe3O4 thin films and its antiphase boundaries prepared by pulsed laser deposition, J Appl Phys, 89, 7398, 10.1063/1.1358831
Kim, 2001, Superparamagnetic iron oxide nanoparticles for bio-medical applications, Scr Mater, 44, 1713, 10.1016/S1359-6462(01)00870-3
Coey, 1971, Noncollinear spin arrangement in ultrafine ferrimagnetic crystallites, Phys Rev Lett, 27, 1140, 10.1103/PhysRevLett.27.1140
Varanda, 2002, Structural and magnetic transformation of monodispersed iron oxide particles in a reducing atmosphere, J Appl Phys, 92, 2079, 10.1063/1.1496124
Held, 2001, Competing interactions in dispersions of superparamagnetic nanoparticles, Phys Rev, B 64, 12408, 10.1103/PhysRevB.64.012408
Collier JH, Messersmith PB. Biomimetic mineralization, mesoporous structures, Encyclopedia Mater Sci Technol 2001;602–6.
Sinha, 2000, Synthesis of organized inorganic crystal assemblies, Curr Sci, 79, 646
Rosensweig RE. Ferrohydrodynamics. Cambridge: 1985.
Tillotson, 2001, Nanostructured energetic materials using sol–gel methodologies, J Non-Cryst Solids, 285, 335, 10.1016/S0022-3093(01)00477-X
Deng, 2003, Preparation of magnetic polymeric particles via inverse microemulsion polymerization process, J Magn Magn Mater, 257, 69, 10.1016/S0304-8853(02)00987-3
Santra, 2001, Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion, Langmuir, 17, 2900, 10.1021/la0008636
Li, 2000, Structured materials synthesis in a self-assembled surfactant mesophase, Colloids Surf A, 174, 275, 10.1016/S0927-7757(00)00538-0
Okamura, 2001, A magnetosome-specific GTPase from the magnetic bacterium Magnetospirillum magneticum AMB-1, J Biol Chem, 276, 48183, 10.1074/jbc.M106408200
Yaacob, 1994, Synthesis and characterization of magnetic nanoparticles in spontaneously generated vesicles, J Coll Int Sci, 168, 289, 10.1006/jcis.1994.1423
Bagwe, 2001, Improved drug delivery using microemulsions, Crit Rev Ther Drug Carrier Syst, 18, 77
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45(1) 89–121
Fendler, 1987, Atomic and molecular clusters in membrane mimetic chemistry, Chem Rev, 87, 877, 10.1021/cr00081a002
Sugimoto, 1987, Preparation of monodispersed colloidal particles, Adv Coll Int Sci, 28, 65, 10.1016/0001-8686(87)80009-X
1983, 73
Muller, 1984, Particle size distributions and particle size alterations in microemulsions, J Pharm Sci, 73, 919, 10.1002/jps.2600730714
Munshi, 1997, Size modulation of polymeric nanoparticles under controlled dynamics of microemulsion droplets, J Colloid Interface Sci, 190, 387, 10.1006/jcis.1997.4889
Igartua, 2002, Development and characterization of solid lipid nanoparticles loaded with magnetite, Int J Pharm, 233, 149, 10.1016/S0378-5173(01)00936-X
Bhandarkar, 1990, Synthesis of nanocomposite particles by intravesicular coprecipitation, J Coll Int Sci, 139, 541, 10.1016/0021-9797(90)90127-A
Shibli, 2001, The effect of the ferrofluid magnetic particle concentration on the thermal diffusivity, Braz J Phys, 31, 418, 10.1590/S0103-97332001000300012
Yaacob, 1995, Magnetic nanoparticles produced in spontaneous cationic–anionic vesicles—room temperature synthesis and characterization, J Coll Interf Sci, 171, 73, 10.1006/jcis.1995.1152
Bailey, 1983, Lesser known applications of ferrofluids, J Magn Magn Mater, 39, 178, 10.1016/0304-8853(83)90428-6
Charles, 1980, Progress in the development of ferromagnetic liquids, IEEE Trans Magn, 16, 172, 10.1109/TMAG.1980.1060584
Khalafalla, 1980, Preparation of dilution-stable aqueous magnetic fluids, IEEE Trans Magnet, 16, 178, 10.1109/TMAG.1980.1060578
Hamley, 2003, Nanotechnology with soft materials, Angew Chem Int Ed, 42, 1692, 10.1002/anie.200200546
Tepper, 2003, Magneto-optical properties of iron oxide films, J Appl Phys, 93, 6948, 10.1063/1.1540033
Mendenhall, 1996, Optimization of long-term stability of magnetic fluids from magnetite and synthetic polyelectrolytes, J Coll Interf Sci, 184, 519, 10.1006/jcis.1996.0647
Salzman, 1983, Polyethyleneglycol oxide as a biomaterial, Am J Soc Artif Intern Organs, 6, 60
Yu, 2003, Structure and magnetic properties of SiO2 coated Fe2O3 nanoparticles synthesized by chemical vapor condensation process, Rev Adv Mater Sci, 4, 55
Liz-Marzán, 2003
Miller, 1983, Morphological changes of ethylene/vinyl acetate based on controlled delivery systems during release of water-soluble solutes, J Memb Sci, 14, 79, 10.1016/S0376-7388(00)81375-7
Zhao, 1998, Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein, J Pharm Sci, 87, 1450, 10.1021/js980065o
Ruiz, 1991, In vivo peptide release from poly(lactic-co-glycolic acid) copolymer 50/50 microspheres, J Cont Rel, 16, 177, 10.1016/0168-3659(91)90041-B
Li, 1997, A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery, J Pharm Sci, 86, 891, 10.1021/js970084i
Akiyoshi, 1996, Supramolecular assembly of hydrophobized polysaccharides, Supramol Sci, 3, 157, 10.1016/0968-5677(96)00031-4
Jeong, 1999, Self assembling nanospheres of hydrophobized pullulans in water, Drug Dev Ind Pharm, 25, 917, 10.1081/DDC-100102252
Schwick, 1969, Immunochemistry and immunology of collagen and gelatin, Bibliotheca Haematol, 3, 111
Massia, 2000, Surface immobilized dextran limits cell adhesion and spreading, Biomaterials, 21, 2253, 10.1016/S0142-9612(00)00151-4
Denizot, 1999, Phosphorylcholine coating of iron oxide nanoparticles, J Coll Interf Sci, 209, 66, 10.1006/jcis.1998.5850
Dresco, 1999, Preparation and properties of magnetite and polymer magnetite nanoparticles, Langmuir, 15, 1945, 10.1021/la980971g
Vladimir, 1999, Physical and chemical properties of magnetite and magnetite-polymer nanoparticles and their colloidal dispersions, J Coll Interf Sci, 212, 49, 10.1006/jcis.1998.5993
Yee, 1999, Self assembled monolayers of alkanesulfonic and phosphonic acids on amorphous iron oxide nanoparticles, Langmuir, 15, 7111, 10.1021/la990663y
Sahoo, 2001, Alkyl phosphonate/phosphate coating on magnetite nanoparticles, Langmuir, 17, 7907, 10.1021/la010703+
Scholten, 1978
Rosensweig, 1969, Viscosity of magnetic fluid in a magnetic field, J Colloid Interf Sci, 29, 680, 10.1016/0021-9797(69)90220-3
Janik, 1997, Shear of molecularly confined liquid crystals. 1. Orientation and transition under confinement, Langmuir, 13, 4466, 10.1021/la960452i
Klein, 1991, Forces between polymer-bearing surfaces undergoing shear, Nature, 352, 143, 10.1038/352143a0
Portet, 2001, Nonpolymeric coatings of iron oxide colloids for biological use as magnetic resonance imaging contrast agents, J Coll Interf Sci, 238, 37, 10.1006/jcis.2001.7500
Berry, 2003, Dextran and albumin derivatised iron oxide nanoparticles, Biomaterials, 24, 4551, 10.1016/S0142-9612(03)00237-0
Gupta, 1989, Magnetically controlled targeted micro-carrier systems, Life Sci, 44, 175, 10.1016/0024-3205(89)90593-6
Ugelstad, 1993, Monodisperse magnetic polymer particles. New biochemical and biomedical applications, Blood Purif, 11, 349, 10.1159/000170129
Kawaguchi, 1996, Modification and functionalization of hydrogel microspheres, Colloids & Surfaces A Physicochem Eng Aspects, 109, 147, 10.1016/0927-7757(95)03482-X
Sauzedde, 1999, Hydrophilic magnetic polymer latexes 1. Adsorption of magnetic iron oxide nanoparticles onto various cationic latexes, Colloid Polym Sci, 277, 846, 10.1007/s003960050461
Sauzedde, 1999, Hydrophilic magnetic polymer latexes 2. Encapsulation of adsorbed iron oxide nanoparticles, Colloid Polym Sci, 277, 1041, 10.1007/s003960050488
Furusawa, 1994, Synthetic process to control the total size and component distribution of multilayer magnetic composite particles, Colloid Polym Sci, 272, 1104, 10.1007/BF00652379
Chatterjee, 2001, Modification and characterization of polystyrene-based magnetic microspheres and comparison with albumin-based magnetic microspheres, J Magn Magn Mater, 225, 21, 10.1016/S0304-8853(00)01223-3
Lee, 1996, Preparation of ultrafine Fe3O4 particles by precipitation in the presence of PVA at high pH, J Coll Interf Sci, 490, 10.1006/jcis.1996.0062
Ng, 2002, Nanostructure array fabrication with temperature-controlled self-assembly techniques, Nanotechnology, 13, 554, 10.1088/0957-4484/13/5/302
Kataby, 1998, Coating of amorphous iron nanoparticles by long-chain alcohols, Langmuir, 14, 1512, 10.1021/la970978i
Capek, 2001, Microemulsion polymerization of styrene in the presence of a cationic emulsifier, Adv Colloid Interf Sci, 92, 195, 10.1016/S0001-8686(00)00072-5
Jiles, 1991
Grüttner, 1997, Preparation and characterization of magnetic nanospheres for in vivo application, 53
Torchilin, 1995, Which polymers can make nanoparticulate drug carriers long-circulating, Adv Drug Del Rev, 16, 141, 10.1016/0169-409X(95)00022-Y
Florence, 1997, The oral absorption of micro- and nanoparticulates, Pharm Res, 14, 259, 10.1023/A:1012029517394
Chen, 2003, Gold-coated iron nanoparticles for biomedical applications, J Appl Phys, 93, 7551, 10.1063/1.1555312
Lin, 2001, Gold-coated iron (Fe@Au) nanoparticles, J Solid State Chem, 159, 26, 10.1006/jssc.2001.9117
Carpenter, 2001, Iron nanoparticles as potential magnetic carriers, J Magn Magn Mater, 225, 17, 10.1016/S0304-8853(00)01222-1
Zhou, 2001, Nanostructures of gold coated iron core-shell nanoparticles and the nanobands assembled under magnetic field, Eur Phys J D, 16, 289, 10.1007/s100530170112
Ulman, 1996, Formation and structure of self-assembled monolayers, Chem Rev, 96, 1533, 10.1021/cr9502357
Mulvaney, 2000, Silica encapsulation of quantum dots and metal clusters, J Mater Chem, 10, 1259, 10.1039/b000136h
Tartaj, 2002, Synthesis of nanomagnets dispersed in colloidal silica cages with applications in chemical separation, Langmuir, 18, 4556, 10.1021/la025566a
Tartaj, 2001, Single-step nanoengineering of silica coated maghemite hollow spheres with tunable magnetic properties, Adv Mater, 13, 1620, 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z
Santra, 2001, Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion, Langmuir, 17, 2900, 10.1021/la0008636
Morawski, 2004, Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI, Magn Reson Med, 51, 480, 10.1002/mrm.20010
Shepherd, 1970, A method of producing ferrofluid with gadolinium particles, J Phys D Appl Phys, 3, 1985, 10.1088/0022-3727/3/12/430
Xu, 1992, Aerosol synthesis of gadolinium iron garnet particles, J Mater Res, 7, 712, 10.1557/JMR.1992.0712
Roberts, 2002, Chemistry for peptide and protein PEGylation, Adv Drug Del Rev, 54, 459, 10.1016/S0169-409X(02)00022-4
Chen, 1986
Sorensen, 2001, 169
Elliott, 1998
Sato, 1987, Magnetic properties of ultrafine ferrite particles, J Magn Magn Mater, 65, 252, 10.1016/0304-8853(87)90044-8
Dormann, 1997, vol. 98, 283
Li, 2002, Hall magnetometry on a single iron nanoparticle, Appl Phys Lett, 80, 4644, 10.1063/1.1487921
Han DH, Wang JP, Luo HL. Crystallite size effect on saturation magnetization of fine ferrimagnetic particles. J Magn Magn Mater 136(1–2):176–82.
Tourinho, 1989, Synthesis and magnetic properties of manganese and cobalt ferrofluids, Prog Colloid Polym Sci, 79, 128, 10.1007/BFb0116198
Gomez-Lopera, 2001, Synthesis and characterization of spherical magnetite/biodegradable polymer composite particles, J Colloid Interf Sci, 240, 40, 10.1006/jcis.2001.7579
Voit, 2001, Magnetic behavior of coated superparamagnetic iron oxide nanoparticles in ferrofluids, Mater Res Soc Symp Proc, 676, Y7.8.1, 10.1557/PROC-676-Y7.8
Bradbury, 1984, Magnetic size determination for interacting fine particle systems, IEEE Trans Magn, 20, 1846, 10.1109/TMAG.1984.1063338
Olsvik, 1994, Magnetic separation techniques in diagnostic microbiology, Clin Microbiol Rev, 7, 43, 10.1128/CMR.7.1.43
Yeh, 1993, Intracellular labeling of T-cells with superparamagnetic contrast agents, Magn Reson Med, 30, 617, 10.1002/mrm.1910300513
Handgretinger, 1998, Isolation and transplantation of autologous peripheral CD34+progenitor cells highly purified by magnetic-activated cell sorting, Bone Marrow Transplant, 21, 987, 10.1038/sj.bmt.1701228
Schoepf, 1998, Intracellular magnetic labelling of lymphocytes for in vivo trafficking studies, BioTechniques, 24, 642, 10.2144/98244rr01
1983
Weissleder, 1997, Magnetically labelled cells can be detected by MR imaging, J Magn Reson Imaging, 7, 258, 10.1002/jmri.1880070140
Bilbao, 1998, 365
Qian, 2002, Targeted drug delivery via transferrin receptor-mediated endocytosis pathway, Pharmacol Rev, 54, 561, 10.1124/pr.54.4.561
Lauffenburger, 1993
Cotter, 1995, Cell death (apoptosis) in cell culture systems, Trends Biotechnol, 13, 150, 10.1016/S0167-7799(00)88926-X
Gupta AK, Curtis ASG. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles: preparation, characterization and their influence on human dermal fibroblasts in culture. Proceedings of the 30th Annual Symposium of Controlled Release of Bioactive Materials, vol. 30, 2003. p. 788.
Gupta, 2003, Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis, IEEE Trans Nanobiosci, 2, 256, 10.1109/TNB.2003.820279
Zola, 1994, Detection of receptors for cytokines and growth factors, Immunologist, 2, 47
Florin, 1994, Adhesion forces between individual ligand–receptor pairs, Science, 264, 415, 10.1126/science.8153628
Pierres, 1996, Measuring bonds between surface-associated molecules, J Immunol Methods, 196, 105, 10.1016/0022-1759(96)00103-2
Tchikov, 2001, Adhesion of immunomagnetic particles targeted to antigens and cytokine receptors on tumor cells determined by magnetophoresis, J Magn Magn Mater, 225, 285, 10.1016/S0304-8853(00)01252-X
Hayat, 1991, vols 1–13
Massia, 2000, Surface immobilized dextran limits cell adhesion and spreading, Biomaterials, 21, 2253, 10.1016/S0142-9612(00)00151-4
Bourke, 2003, Polymers derived from the amino acid l-tyrosine, Adv Drug Del Rev, 55, 447, 10.1016/S0169-409X(03)00038-3
Brandley, 1998, Covalent attachment of an Arg-Gly-Asp sequence peptide to derivatizable polyacrylamide surfaces, Anal Biochem, 172, 270, 10.1016/0003-2697(88)90442-3
Nakajima, 1990, Adsorption of plasma proteins on Arg-Gly-Asp-Ser peptide-immobilized poly(vinylalcohol) and ethylene-acrylic copolymer films, Polym J, 22, 985, 10.1295/polymj.22.985
Osterberg, 1993, Comparison of polysachharide and poly(ethylene glycol) coatings for reduction of protein adsorption on polystyrene surfaces, Colloids Surf A Physicochem Eng Asp, 77, 159, 10.1016/0927-7757(93)80112-R
Holland, 1998, Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers, Nature, 392, 477, 10.1038/33894
Frazier, 1997, In situ surface plasmon resonance analysis of dextran monolayer degradation by dextranase, Langmuir, 13, 7115, 10.1021/la970382v
Crepon, 1991, Enzymatic degradation and immunogenic properties of derivatized dextrans, Biomaterials, 12, 550, 10.1016/0142-9612(91)90049-G
Wilhelm, 2003, Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating, Biomaterials, 24, 1001, 10.1016/S0142-9612(02)00440-4
Josephson, 1999, High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates, Bioconj Chem, 10, 186, 10.1021/bc980125h
Bulte, 2001, Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells, Nat Biotechnol, 19, 1141, 10.1038/nbt1201-1141
Mutsaers, 1988, Surface charge of macrophages and their interaction with charged particles, J Leukoc Biol, 44, 17, 10.1002/jlb.44.1.17
Farquhar, 1978, Recovery of surface membrane in anterior pituitary cells variations in traffic detected with anionic and cationic ferritin, J Cell Biol, 77, R35, 10.1083/jcb.77.3.R35
Ghinea, 1985, Anionized and cationized hemeundecapeptides as probes for cell surface charge and permeability studies, J Cell Biol, 100, 606, 10.1083/jcb.100.2.606
Josphson, 1990, A functionalised superparamagnetic iron oxide colloid as a receptor directed MR contrast agent, Magn Reson Imaging, 8, 637, 10.1016/0730-725X(90)90143-P
Moore, 1998, Measuring transferrin receptor gene expression by NMR imaging, Biochim Biophys Acta, 1402, 239, 10.1016/S0167-4889(98)00002-0
Bulte, 1999, Neurotransplantation of magnetically labeled oligodendrocyte progenitors, Proc Natl Acad Sci USA (online), 96, 15256, 10.1073/pnas.96.26.15256
Weissleder, 1997, Magnetically labelled cells can be detected by MR imaging, Magn Reson Imaging, 7, 258, 10.1002/jmri.1880070140
Berry, 2004, The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture, Int J Pharm, 269, 211, 10.1016/j.ijpharm.2003.09.042
Zhao, 2002, Differential conjugation of Tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake, Bioconjug Chem, 13, 840, 10.1021/bc0255236
Bhorade, 2000, Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a Hiv-Tat derived membrane translocation peptide, Bioconjug Chem, 11, 301, 10.1021/bc990168d
Moore, 2001, Human transferrin receptor gene as a marker gene for MR imaging, Radiology, 221, 244, 10.1148/radiol.2211001784
Nam, 2003, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins, Science, 301, 1884, 10.1126/science.1088755
Nam, 2002, Bio-barcodes based on oligonucleotide-modified nanoparticles, J Am Chem Soc, 124, 3820, 10.1021/ja0178766
Kemmner, 1992, Separation of tumor cells from a suspension of dissociated human colorectal carcinoma tissue by means of monoclonal antibody-coated magnetic beads, J Immunol Methods, 147, 197, 10.1016/S0022-1759(12)80008-1
Kronick, 1986, Use of superparamagnetic for isolation of cells, J Biochem Biophys Methods, 12, 73, 10.1016/0165-022X(86)90052-7
Lobel, 2000, Temperature controlled CO2 laser welding of soft tissues, Lasers Surg Med, 26, 4, 10.1002/(SICI)1096-9101(2000)26:1<4::AID-LSM3>3.0.CO;2-J
Fried, 1999, Radiometric surface temperature measurements during dye-assisted laser skin closure, Lasers Surg Med, 25, 291, 10.1002/(SICI)1096-9101(1999)25:4<291::AID-LSM4>3.0.CO;2-#
Xu, 2004, Strong and bioactive composites containing nano-silica-fused whiskers for bone repair, Biomaterials, 25, 4615, 10.1016/j.biomaterials.2003.12.058
Sokolov, 2003, Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles, Cancer Res, 63, 1999
Kiessling, 2003
Bulte, 2001, Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells, Nat Biotechnol, 19, 1141, 10.1038/nbt1201-1141
Chouly, 1996, Development of superparamagnetic nanoparticles for MRI, J Microencapsul, 13, 245, 10.3109/02652049609026013
Storm, 1995, Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system, Adv Drug Del Rev, 17, 31, 10.1016/0169-409X(95)00039-A
Zhang, 2002, Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake, Biomaterials, 23, 1553, 10.1016/S0142-9612(01)00267-8
Yamazaki, 1990, Deformation and instability of membrane structure of phospholipid vesicles caused by osmophobic association, Biochemistry, 29, 1309, 10.1021/bi00457a029
Widder, 1980, In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres, Cancer Res, 40, 3512
Gupta, 1993, Magnetically controlled targeted chemotherapy, 71
Gallo, 1989, Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat, J Pharmacokinet Biopharm, 17, 305, 10.1007/BF01061899
Gallo, 1989, Evaluation of drug delivery following administration of magnetic albumin microspheres containing adriamycin to the rat, J Pharm Sci, 78, 190, 10.1002/jps.2600780303
Zimmermann, 1980, Development of drug carrier systems, Bioelectrochem Bioenerg, 7, 553, 10.1016/0302-4598(80)80014-6
Freeman, 1965, Intestinal fat and iron transport, goblet cell mucus secretion, and cellular changes in protein deficiency observed with the electron microscope, Am J Dig Dis, 10, 1005, 10.1007/BF02233375
Meyers, 1966, Pathologic studies following magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent, Am J Roentgenol Radium Ther Nucl Med, 96, 913, 10.2214/ajr.96.4.913
Gallo, 1993, Targeting anticancer drugs to the brain, J Pharmacokinet Biopharm, 21, 575, 10.1007/BF01059115
Hirao, 2003, Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field, Int J Oncol, 22, 1065
Choi, 2003, Surface modification of functional nanoparticles for controlled drug delivery, J Dispersion Sci Technol, 24, 2003, 10.1081/DIS-120021803
PaÈuser, 1997, Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers, Anticancer Drug Des, 12, 125
Kubo, 2000, Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters, Int J Oncol, 17, 309
Kubo, 2001, Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters, Int J Oncol, 18, 121
Wilbanks, 1990, Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes, Immunology, 71, 566
Isabelle, 1997, Enhancement of cytokine expression in transiently transfected cells by magnetoliposome mediated hyperthermia, Cytotechnology, 25, 231, 10.1023/A:1007930925862
Gupta, 2004, Surface modified superparamagnetic nanoparticles for drug delivery, J Mater Sci Mater Med, 15, 493, 10.1023/B:JMSM.0000021126.32934.20
Najafi, 2003, Biodegradable micelles/polymersomes from fumaric/sebacic acids and poly(ethylene glycol), Biomaterials, 24, 1175, 10.1016/S0142-9612(02)00487-8
Otsuka, 2003, PEGylated nanoparticles for biological and pharmaceutical applications, Adv Drug Deliv Rev, 54, 403, 10.1016/S0169-409X(02)00226-0
Chilkoti, 2002, Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery, Adv Drug Deliv Rev, 54, 1093, 10.1016/S0169-409X(02)00060-1
Weissleder, 1995, Long circulating iron oxides for MR imaging, Adv Drug Deliv Rev, 16, 321, 10.1016/0169-409X(95)00033-4
Johnson, 1993, Histology by magnetic resonance microscopy, Mag Reson, Q9, 1
Fawell, 1994, Tat-mediated delivery of heterologous proteins into cells, Proc Natl Acad Sci USA, 91, 664, 10.1073/pnas.91.2.664
Lewin, 2000, Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, Nat Biotechnol, 18, 410, 10.1038/74464
Enochs, 1999, Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent, J Magn Reson Imag, 9, 228, 10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.0.CO;2-K
Zhao, 2001, Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent, Nat Med, 7, 1241, 10.1038/nm1101-1241
Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464
Poptani, 1998, Monitoring thymidine kinase and gancyclovir induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging, Cancer Gene Ther, 5, 101
Francis, 1997, Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy, Blood, 89, 3778, 10.1182/blood.V89.10.3778
Nunn, 1996, Characterisation of secondary metabolites associated with neutrophil apoptosis, FEBS Lett, 392, 295, 10.1016/0014-5793(96)00839-3
Nielsen, 2001, A future for hyperthermia in cancer treatment?, Eur J Cancer, 37, 1587, 10.1016/S0959-8049(01)00193-9
Gordon, 1979, Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations, Med Hypothesis, 5, 83, 10.1016/0306-9877(79)90063-X
Luderer, 1983, Glass-ceramic-mediated, magnetic-field-induced localized hyperthermia, Radiat Res, 94, 190, 10.2307/3575874
Chan, 1993, Synthesis and evaluation of colloidal magnetic iron oxides for the site specific radiofrequency-induced hyperthermia of cancer, J Magn Magn Mater, 122, 374, 10.1016/0304-8853(93)91113-L
Sneed PK, Stea B. In: Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Thermoradiotherapy and thermochemotherapy, vol 2. Berlin: Springer; 1996.
Jordan, 1999, Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro, J Magn Magn Mater, 194, 185, 10.1016/S0304-8853(98)00558-7
Wada, 2003, Antitumor effect of new local hyperthermia using dextran magnetite complex in hamster tongue carcinoma, Oral Dis, 9, 218, 10.1034/j.1601-0825.2003.02839.x
Ito, 2001, Heat-inducible TNF-α gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy, Cancer Gene Ther, 8, 649, 10.1038/sj.cgt.7700357
Krotz, 2003, Magnetofection—a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo, Mol Ther, 7, 700, 10.1016/S1525-0016(03)00065-0
Krotz, 2003, Magnetofection potentiates gene delivery to cultured endothelial cells, J Vasc Res, 40, 425, 10.1159/000073901
Krotz, 2003, Magnetofection—a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo, Mol Ther, 7, 700, 10.1016/S1525-0016(03)00065-0
Yuen, 1974, Pullulan and its applications, Process Biochem, 9, 7
Kaneo, 2001, Evidence for receptor mediated hepatic uptake of pullulan in rats, J Cont Rel, 70, 365, 10.1016/S0168-3659(00)00368-0
Baker, 1998, Albumin's role in steroid hormone action and the origins of vertebrates, FEBS Lett, 439, 9, 10.1016/S0014-5793(98)01346-5
Bhadriraju, 2000, Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins, Biomaterials, 21, 267, 10.1016/S0142-9612(99)00175-1
D’Souza, 2004, Polyvinylpyrrolidone–drug conjugate, J Cont Rel, 94, 91, 10.1016/j.jconrel.2003.09.014
Shan, 2003, Immobilization of Pseudomonas delafieldii with magnetic polyvinyl alcohol beads and its application in biodesulfurization, Biotechnol Lett, 25, 1977, 10.1023/B:BILE.0000004388.15751.8c
Burugapalli, 2004, Effect of composition of interpenetrating polymer network hydrogels based on poly(acrylic acid) and gelatin on tissue response, J Biomed Mater Res, 68A, 210, 10.1002/jbm.a.10117
Chen, 1993, Preparation and properties of thermoreversible, phaseseparating enzyme-oligo(N-isopropylacrylamide) conjugates, Bioconjug Chem, 4, 509, 10.1021/bc00024a013
Khor, 2003, Implantable applications of chitin and chitosan, Biomaterials, 24, 2339, 10.1016/S0142-9612(03)00026-7
Olsen, 2003, Recombinant collagen and gelatin for drug delivery, Adv Drug Deliv Rev, 55, 1547, 10.1016/j.addr.2003.08.008